All In MedTech

Device Trial Radar · NCT02353533

Endoscopic Full-thickness REsection of Residual Colorectal Lesions - The FiRE Study

Last checked: Nov 19, 2026Latest source record: Nov 21, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

40

Planned (sponsor's estimate)

Start

Jan 2015

Primary completion

Oct 2017

Study completion Dec 2017

Sponsor

Lead sponsor
Technical University of MunichAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Feb 2, 2015

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Adenomatous lesions of the colon are premalignant lesions which have the potential to develop cancer. Therefore adenomas should be resected endoscopically (endo- mucosa resection, EMR). EMR is conducted after submucosal injection of saline which allows to lift the desired lesion prior to resection. In some cases EMR is complicated due to incomplete or failed lifting after the injection of saline. This so- called "non- lifting" sign is a predictor for malignancy of the lesion. Difficult- to- lift polyps are also difficult- to- resect. A higher proportion of these lesions fail to be resected completely using the EMR technique. Alternatively, an over- the- scope full- thickness resection device (FTRD) can be used in order to resect colonic lesions. The FTRD technique has been described elsewhere (Schmidt et al. Gastroenterology 2014; 147: 740-742.e2). No comparative data exists until now on the performance of FTRD resection compared to standard EMR resection of difficult- to- resect colon adenomas. In this study the investigators aim to compare the success of FTRD versus EMR of difficult- to- resect adenomatous lesions (≤ 20 mm).

Conditions

  • Adenoma

Interventions

  • over- the- scope full- thickness resection device (FTRD)Device

    Endoscopic resection of adenomatous lesions of the colon using the over- the- scope full- thickness resection device

  • EMRDevice

    Standard endoscopic mucosal resection using a resection snare

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Success of resectionTime frame: 3 month

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • II Medizinische Klinik am Klinikum rechts der Isar der Technischen Universität München

    Munich, Germany · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.